<DOC>
	<DOCNO>NCT00509132</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerance single intravenous ( vein ) dose trodusquemine . Different amount trodusquemine give volunteer group throughout study . Another purpose evaluate pharmacokinetics ( PK - study way drug enters leave blood tissue time ) trodusquemine . Finally , study also determine whether trodusquemine effect appetite , mood behavior , selective biomarkers ( substance blood may change response study drug ) .</brief_summary>
	<brief_title>A Tolerance Pharmacokinetic Study Trodusquemine Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>male female subject , 18 55 year old ( inclusive ) ; body mass index ( BMI ) 2740 kg/m2 ; likely allergy sensitivity component Trodusquemine Injection base know allergy drug class , , opinion Principal Investigator , suggest increase potential adverse hypersensitivity trodusquemine HCl ; subject history allergy ( rash , hive , breathe difficulty , etc . ) medication , either prescription nonprescription , include dietary supplement herbal medication ; subject history severe allergy bronchial asthma ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>